24H | Moderna and TotalEnergies Jump 8%; GitLab Drops 8%; Arbutus Biopharma Sinks 12%

Tiger Newspress
03/04

Moderna has agreed to pay Genevant Sciences, a subsidiary ​of Roivant Sciences, and Arbutus Biopharma up to $2.25 billion to settle ‌a long-running legal fight over the technology that made its COVID-19 vaccine possible, the companies said. Moderna shares jumped 7.5% in overnight trading, while Arbutus Biopharma dropped 12.4%.

TotalEnergies has agreed to divest a 50% stake in 11 battery storage projects in Germany, with a combined capacity ranging from 789MW to 1.63 gigawatt-hours (GWh), to Allianz Global Investors (AllianzGI). TotalEnergies shares gained 7.5% in overnight trading.

GitLab expects sales to slow this year and outlined several initiatives to help boost guidance that its chief executive officer described as disappointing. The shares sank 8% in overnight trading.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10